NewsBite

Exclusive

Bubs cuts US staff as it readies for FDA visit

Carrie LaFrenz
Carrie LaFrenzSenior reporter

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

The US Food and Drug Administration will audit Bubs Australia’s Deloraine, canning facility in Victoria next week as the infant formula company further axes jobs at its US office.

Former Bubs CEO Kristy Carr and executive chairman Dennis Lin are also suing Bubs and the non-executive directors of the baby formula group – Katrina Rathie, Steven Lin, Reg Weine and Paul Jensen – in the Victorian Federal Court over their removal from the company co-founded by Ms Carr.

Loading...

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Latest In Manufacturing

Fetching latest articles

Most Viewed In Companies

    Original URL: https://www.afr.com/companies/manufacturing/bubs-swings-the-axe-at-us-operations-20230605-p5de1e